RWEpi

Responsable del grupo
avatar_investigadors.jpg
Talita Duarte Salles
avatar_grups_recerca.png

Publicaciones

A mixed methods study protocol for CONFIVAC, an intervention to enhance paediatric nurses’ and paediatricians’ skills to promote vaccination and vaccine confidence

E. HENDERSON, S. VALMAYOR, V. PORTHÉ, A. ASENSIO, X. BRUNA, U. ELIZONDO-ALZOLA, A. RAMIREZ-MORROS, G. RICÓS, J. VIDAL-ALABALL, M. PASARÍN, C. RIUS, E. ROEL and E. DÍEZ
Vaccine: X. 2025 Jun 1; . doi:10.1016/j.jvacx.2025.100635;

  • Ans: 01/06/2025
  • FI:
Prevalence of Dermatomyositis and Polymyositis in Adults and Paediatric Populations: A Network Cohort Study Part of DARWIN EU®

A. PRATS-URIBE, K. LÓPEZ-GÜELL, L. ELHUSSEIN, E. BURN, L. BELLAS, F. DERNIE, A. DELMESTRI, W. MAN, H. OMULO, J. BRASH, H. BALLEGOOIJEN, T. DUARTE-SALLES, N. MERCADÉ-BESORA, L. PEREZ, R. GRIFFIER, S. SEAGER, M. OJA and D. PRIETO-ALHAMBRA
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024 Nov 1;

  • Ans: 01/11/2024
  • FI: 2.4
DARWIN EU®-Risk of Thromboembolic Events Associated With COVID-19 During the Omicron Period, and SARS-CoV-2 Vaccination

M. CATALÀ, A. JÖDICKE, K. VERHAMME, M. MOSSEVELD, J. BRASH, S. SEAGER, L. PÉREZ-CRESPO, N. MERCADÉ-BESORA, T. DUARTE-SALLES, M. OJA, E. BURN, A. PRATS-URIBE, D. PRIETO-ALHAMBRA, R. KOLDE and X. LI
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024 Nov 1;

  • Ans: 01/11/2024
  • FI: 2.4
EFFECTIVENESS OF OSTEOPOROSIS DRUGS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A POPULATION-BASED COHORT STUDY

L. RODRÍGUREZ, J. POVEDA, C. CARBONELL-ABELLA, C. REYES, M. GIMÉNEZ, C. TORNÉ and D. MARTINEZ-LAGUNA
AGING CLINICAL AND EXPERIMENTAL RESEARCH. 2024 Aug 1;

  • Ans: 01/08/2024
  • FI: 3.4
PREDICTING LONG TERM CANCER SURVIVAL FOR HEALTH TECHNOLOGY ASSESSMENT: A MULTINATIONAL COHORT STUDY

R. CLAIRE, J. DIETZ, . KOBLBAUER, J. KOH, J. ELVIDGE, . LÓPEZ-SÁNCHEZ, A. GOLOZAR, L. PÉREZ-CRESPO, A. CROS, E. BURN, A. ROBINSON, A. DELMESTRI, G. CORBY, M. HERRAIZ, M. SABATÉ, W. MAN, X. CHEN, M. MAYER, J. ANGUITA, A. MACHIN, N. SYMMERS, M. VALLET, C. MCLEAN, P. HALL, E. ENERLY, P. PRINSEN, J. EVERS, M. OJA, R. KOLDE, E. FEY, T. TAVEIRA-GOMES, E. FOURNIER, A. CONDE, T. KAUKO, R. GRAGERA, M. MOSSEVELD, K. VERHAMME, T. DUARTE-SALLES, D. DAWOUD and D. NEWBY
VALUE IN HEALTH. 2024 Dec 1;

  • Ans: 01/12/2024
  • FI: 4.9